BCM
GNFT

BlueCrest Capital Management’s Genfit GNFT Stock Holding History

BlueCrest Capital Management’s Portfolio GNFT Stock Details GNFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,000
Closed -$240K – 684
2019
Q1 		$240K Buy
+10,000
New +$231K 0.01% 836

Other funds holding GNFT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BlueCrest Capital Management's GNFT Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Genfit (GNFT) in Q2 2019, closing a stake of 10,000 shares — an estimated $240K sold.

BlueCrest Capital Management first reported a position in GNFT in Q1 2019 and held it in 1 quarter. The position peaked at $240K in Q1 2019. 24 funds tracked by Wall St. Rank hold GNFT as of Q2 2019.

  • BlueCrest Capital Management reported no remaining Genfit position as of Q2 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 10,000 Genfit shares in Q2 2019, an estimated $240K.
  • BlueCrest Capital Management first reported a position in Genfit in Q1 2019 and held it in 1 quarter.
  • BlueCrest Capital Management's Genfit position peaked at $240K in Q1 2019.
  • 24 funds tracked by Wall St. Rank held Genfit as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.